Average deductibles for Obamacare bronze plans will top $6,000 for individuals for the first time next year. » Read More
A company has been created to develop "novel technology" to help treat type 1 diabetes and potentially negate the need for insulin injections.
An invention that debuted Thursday could let you see all the spots you're missing when you brush.
IBM's World Community Grid links volunteers' personal computers and mobile devices to form a supercomputer for disease research.
A rare and previously unknown variation in some people's genes substantially reduces their heart attack risk, the Icelandic researchers said.
No link between meal timing and obesity: The findings fly in the face of previously published studies, but there are limitations.
Drug-resistant infections - or "superbugs" – could claim 10 million lives a year and could cost a cumulative $100 trillion of economic output by 2050.
German drug and chemicals giant Bayer has made an unsolicited takeover offer for Monsanto, the world's biggest seed company.
Highmark has gotten just a small fraction of the approximately $223 million it says the federal government owes it.
Theranos has informed authorities of its decision to issue corrected blood-test reports to doctors and patients, The Wall Street Journal reports.
From ninja-like "Infinity Burial Suits" to becoming part of a mushroom patch, there are some seriously cool disruptions happening to death, says VC Lisa Suennen.
Zika, the mosquito-borne virus, could reach Europe's borders as soon as late spring or this summer, a UN health agency warned Wednesday.
J&J's consumer brands and medical devices units are poised for growth following turnaround efforts, CEO Alex Gorsky says.
The Obama administration is finally giving employers rules for wellness programs that won’t violate privacy and discrimination regulations.
Capsule says its home-delivery prescription service will be faster and simpler for many consumers.
Citron's Andrew Left says he does not think Valeant shares will trade above $60 anytime soon.
Shortly after releasing its initial results, Perrigo revised its net loss figures to be lower than originally stated.
Get the best of CNBC in your inbox